Fred Kurland
Keine laufenden Positionen mehr
Vermögen: 312 $ am 31.03.2024
Profil
Fred Kurland formerly worked at Applied Immune Sciences, Inc., as Chief Financial Officer & Vice President from 1995 to 1996, Protein Design Labs, Inc., as Chief Financial Officer & Vice President from 1996 to 1998, Syntex Corp., as Vice President & Controller from 1991 to 1995, MedImmune Vaccines, Inc., as Chief Financial Officer & Senior Vice President from 1998 to 2002, XOMA Corp., as Chief Financial Officer, Secretary & VP from 2013 to 2015, Corcept Therapeutics, Inc., as Chief Financial Officer from 2004 to 2007, Genitope Corp., as Chief Financial Officer & Vice President from 2002 to 2004, Bayhill Therapeutics, Inc., as Chief Financial Officer, Aridis Pharmaceuticals, Inc., as Chief Financial & Accounting Officer, and Aridis Pharmaceuticals, Inc., as Chief Financial Officer from 2015 to 2019.
Mr. Kurland received his graduate degree and Masters Business Admin degree from The University of Chicago and undergraduate degree from Lehigh University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2023 | 4 000 ( 0,01% ) | 312 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Fred Kurland
| Unternehmen | Position | Ende |
|---|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 04.08.2023 |
| ARIDIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 31.12.2019 |
| XOMA CORPORATION | Director of Finance/CFO | 03.04.2015 |
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Director of Finance/CFO | - |
| CORCEPT THERAPEUTICS INCORPORATED | Director of Finance/CFO | 13.04.2007 |
Ausbildung von Fred Kurland
| The University of Chicago | Graduate Degree |
| Lehigh University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| XOMA CORPORATION | Health Technology |
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| ARIDIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Applied Immune Sciences, Inc.
 Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The private company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Health Technology |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
| Syntex Corp. | Health Technology |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
